THỰC TRẠNG TRẦM CẢM Ở NGƯỜI BỆNH LƠ – XÊ – MI CẤP

Abstract

Background: Depression is common and often causes serious consequences on both the physical and mental health of patients with acute leukemia. The quality of life of patients and the economic burden associated with acute leukemia become more severe. Assessing the current state of depression will contribute to building a clinical picture of depression, thereby having strategies for prevention and treatment, improving the quality of life of these patients. Objectives: To evaluate the rate and some factors related to depressive disorders in patients with acute leukemia. Subjects and methods: Cross-sectional descriptive study on 82 acute leukemia patients at the Center for Hematology and Blood Transfusion - Bach Mai Hospital from August 2021 to August 2022, using the Beck depression assessment scale to determine depression. Results: The rate of depression was 50%, of which mild, moderate and severe levels were 23.2% 17.1% and 9.7%, respectively. There was a statistically significant association between the presence of other comorbidities, chemotherapy treatment methods and PS score ≥ 2 with depression. Conclusion: Depression screening measures are needed for early and appropriate intervention for acute leukemia patients at high risk of agitation.